Healthcare & Life Sciences
Exosome Diagnostics
United Statesexosomedx.com
Exosome Diagnostics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2008
Founded
2
Investors
About Exosome Diagnostics
Exosome Diagnostics is a company founded in 2008 headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Exosome Diagnostics develops molecular diagnostic tests focused on the early detection and risk stratification of aggressive prostate cancer and urologic diseases using personalized genomic assays.
Explore Exosome Diagnostics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.